Novartis announced that they assigned Brian Gladsden as new president and CEO

Published: 2014-01-23 06:56:00

Updated: 2014-01-23 06:56:00

(Yakup Shinmoon)

On Jan 21, Novartis announced that they assigned Brian Gladsden as new president and CEO.

Brian Gladsden, appointed as new CEO and President of Novartis Korea, was in charge of the Novartis cancer drug business department in Australia and New Zealand from 2011 to 2013, and received high praise to have done a crucial role in showing competence of the department.

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.